AffaMed Therapeutics Funding: $170M Raised, Series B (2021)

AffaMed Therapeutics funding overview

AffaMed Therapeutics is based in Shanghai, China. AffaMed Therapeutics has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2021. The round record for AffaMed Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Lake Bleu Capital, Partners Investment, Superstring Capital, Orion Science Capital, Fountainhead Partners, CBC Group. 6 distinct backers are named across the disclosed rounds.

AffaMed Therapeutics at a glance

Total raised: $170M
Latest round: Series B
Latest round date: March 2021
Headquarters: Shanghai, China
Notable investors: Lake Bleu Capital, Partners Investment, Superstring Capital, Orion Science Capital, Fountainhead Partners, CBC Group

Frequently asked about AffaMed Therapeutics funding

How much has AffaMed Therapeutics raised?: AffaMed Therapeutics has raised $170M in total disclosed funding across the rounds on record.
Who has invested in AffaMed Therapeutics?: Lake Bleu Capital, Partners Investment, Superstring Capital, Orion Science Capital, Fountainhead Partners, CBC Group are named among the investors backing AffaMed Therapeutics.
What was the latest AffaMed Therapeutics funding round?: The most recent disclosed round is a Series B, announced in March 2021.
Where is AffaMed Therapeutics based?: AffaMed Therapeutics is based in Shanghai, China.
When did AffaMed Therapeutics last raise?: The last disclosed AffaMed Therapeutics round closed in March 2021 at Series B.

AffaMed Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.

AffaMed Therapeutics Funding: $170M Raised, Series B (2021)

AffaMed Therapeutics funding overview

AffaMed Therapeutics at a glance

Frequently asked about AffaMed Therapeutics funding

Companies related to AffaMed Therapeutics (31)

Browse related funding lists (7)